A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 33/06 (2006.01) A61K 31/44 (2006.01)
Patent
CA 2190847
Pharmaceutically acceptable compositions suitable for releasing magnesium ions to an organism, such as organic or inorganic magnesium salts or complexes thereof, are used to prevent and to treat neoplastic and autoimmune diseases, whose origin can be attributed to magnesium depletion. For the new therapeutic indications the magnesium based product, preferably magnesium pyrophosphate, is usually administered orally or parenterally, preferably in association with vitamin B6.
On utilise des compositions pharmaceutiquement acceptables aptes à libérer des ions magnésium dans un organisme, telles que des sels ou complexes de magnésium organique ou inorganique, afin de prévenir ou de traiter des maladies néoplasiques et auto-immunes dont les origines peuvent être attribuées à un appauvrissement en magnésium. Ce produit à base de magnésium, qui est de préférence du pyrophosphate de magnésium, est généralement administré, selon de nouvelles indications d'ordre thérapeutique, par voie orale ou parentérale, de préférence en association avec la vitamine B¿6?.
Gowling Lafleur Henderson Llp
Valletta Giampiero
LandOfFree
Use of magnesium-based products for the treatment or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of magnesium-based products for the treatment or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of magnesium-based products for the treatment or... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1746918